Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part B - Behavioral results

Table 1 ATEC scores at beginning at beginning of phase 1 and end of phase 2, for those who completed phase 2.

		Initial	St dev	Final	St dev	% change
I. SPLC	7 rounds	13.4	7.7	10.6	7.0	-21%***
	1 round	12.0	8.4	10.5	8.9	-13%
II. Sociability	7 rounds	16.6	8.5	12.1	6.5	-27%***
	1 round	14.9	6.8	11.2	6.5	-25%*
III. Sensory/Cognitive Awareness	7 rounds	16.0	7.4	11.7	7.9	-27%***
	1 round	13.0	6.8	9.6	5.9	-26%*
IV. Health/Physical/Behavior	7 rounds	29.9	14.4	21.6	10.1	-28%**
	1 round	21.5	9.4	18.3	9.2	-15%
ATEC Total	7 rounds	80.8	24.0	60.14	27.9	-26%***
	1 round	66.2	20.7	53.4	23.5	-19%**

* P < 0.05
**P < 0.01
*** P < 0.001
For the 7-round group n = 25 (n = 14 for Section IV & Total), and for the 1-round group n = 15 (n = 10 for Section IV & Total). The statistical significance of the change is indicated, based on a paired t-test.